Frankincense, specifically the extract from the Boswellia serrata tree, shows genuine promise for arthritis pain relief. Clinical trials have found that people taking Boswellia supplements experienced significantly greater reductions in knee pain and stiffness compared to those taking a placebo. It’s not a replacement for standard treatment, but the evidence is stronger than for many other herbal supplements marketed for joint pain.
How Frankincense Reduces Joint Inflammation
The resin of the Boswellia serrata tree contains a group of active compounds called boswellic acids. The most potent of these works by blocking a specific enzyme called 5-lipoxygenase (5-LOX), which your body uses to produce inflammatory molecules called leukotrienes. Leukotrienes promote swelling, attract inflammation-producing cells to joints, and contribute to tissue damage through free radical activity.
What makes boswellic acids interesting compared to other plant-based anti-inflammatories is their precision. Many herbal compounds reduce inflammation in a broad, nonspecific way by acting as general antioxidants. Boswellic acids are different: they specifically target the 5-LOX pathway without affecting other inflammatory enzymes like cyclooxygenase, which is the pathway that drugs like ibuprofen block. This selective action means they reduce a particular type of inflammation through a mechanism that standard painkillers don’t touch, which is partly why researchers have been interested in whether the two approaches might complement each other.
What the Clinical Evidence Shows
A systematic review and meta-analysis published in Seminars in Arthritis and Rheumatism pooled results from multiple randomized controlled trials of Boswellia for knee osteoarthritis. Patients receiving Boswellia formulations had a large, statistically significant reduction in pain compared to placebo, with a standardized mean difference of -2.04. To put that in context, that’s a substantial effect size. When looking specifically at the WOMAC pain subscale, a widely used measure of arthritis symptoms, Boswellia again outperformed placebo significantly (standardized mean difference of -1.37).
These numbers are encouraging, but they come with caveats. The trials were relatively small, and the overall body of evidence is still considered limited. Six major professional rheumatology societies, including the American College of Rheumatology, have reviewed Boswellia and classified it as having “insufficient evidence” to make a formal recommendation for or against its use. That doesn’t mean it doesn’t work. It means the studies conducted so far, while positive, aren’t large or numerous enough to meet the high bar these organizations set for treatment guidelines.
Topical Frankincense for Knee Pain
One challenge with oral Boswellia supplements is that boswellic acids have relatively low bioavailability when swallowed, meaning your body doesn’t absorb them efficiently through the digestive tract. This has led researchers to explore topical application as an alternative route.
A randomized, double-blind, placebo-controlled trial tested a topical oily solution containing enriched boswellic acid extract on patients with knee osteoarthritis. Participants applied the solution to their affected knee three times daily for four weeks. Both pain severity (measured by VAS) and joint function (measured by WOMAC scores) improved significantly more in the treatment group than in the placebo group. This was the first clinical trial to test topical Boswellia for knee osteoarthritis, so the results are preliminary. But the significant improvements across multiple outcome measures suggest that delivering boswellic acids directly to the joint through the skin may be a viable approach, potentially bypassing the absorption problems of oral supplements.
Safety and Side Effects
Boswellia has a reassuring safety profile based on the available evidence. Side effects are few and largely limited to mild, temporary gastrointestinal symptoms: nausea, diarrhea, constipation, or occasional heartburn. In most controlled studies, adverse events occurred no more frequently with Boswellia extracts than with placebo. The National Institutes of Health’s LiverTox database rates Boswellia as an unlikely cause of liver injury, giving it the lowest concern rating.
There is one important exception. Italian surveillance data identified cases where patients taking warfarin (a blood thinner) experienced increased bleeding risk after starting Boswellia products. In two documented cases, blood clotting markers rose significantly within 10 to 30 days of adding a Boswellia supplement, and both patients recovered after stopping it. Laboratory research suggests Boswellia may interfere with the same liver enzymes that metabolize warfarin, effectively amplifying the drug’s blood-thinning effect. If you take warfarin or other anticoagulant medications, this is a combination to avoid or at minimum discuss with your prescriber before trying.
Choosing a Supplement
Not all Boswellia products are equivalent. The key active compound, acetyl-11-keto-β-boswellic acid (commonly abbreviated AKBA), is present in varying concentrations depending on the extract. Clinical research has primarily used standardized extracts containing 20% to 30% AKBA. One well-studied formulation called 5-Loxin contains 30% AKBA, while another called Aflapin contains 20% AKBA in a modified oil base designed to improve absorption. Both have appeared in published trials.
Typical doses used in osteoarthritis studies range from 100 to 250 mg daily of these enriched extracts. If you’re looking at a product on the shelf, check the supplement facts panel for the AKBA percentage and the total boswellic acid content rather than relying on the weight of raw resin, which can be misleading. A product listing 1,000 mg of Boswellia resin with no standardization information may deliver far less of the active compound than a 100 mg extract standardized to 30% AKBA.
Because dietary supplements aren’t regulated with the same rigor as pharmaceuticals, third-party testing certifications (USP, NSF, or ConsumerLab) can provide some assurance that a product actually contains what its label claims.
Where Frankincense Fits in Arthritis Management
Frankincense extract occupies a middle ground in arthritis care: more evidence behind it than most herbal remedies, but not enough to earn a formal recommendation from major medical organizations. The clinical data, particularly for knee osteoarthritis, suggests real benefits for pain and function beyond placebo. Its safety profile is mild enough that most people can try it without significant risk, with the notable exception of those on blood thinners.
It works through a different inflammatory pathway than standard NSAIDs like ibuprofen, which means it’s not a direct substitute for those medications. For people who tolerate NSAIDs well and get adequate relief, there may be little reason to switch. But for those who experience stomach problems with NSAIDs, want to explore complementary options, or are looking for additional relief alongside their current regimen, a standardized Boswellia extract with adequate AKBA content is one of the more evidence-supported natural options available.